UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treat-to-target in axial spondyloarthritis - what about physical function and activity?

Nature reviews. Rheumatology, 2021-09, Vol.17 (9), p.565-576

2021

Volltextzugriff (PDF)

Non-medical switching from reference to biosimilar etanercept - no evidence for nocebo effect: a retrospective analysis of real-life data

Clinical and Experimental Rheumatology, 2021-11, Vol.39 (6), p.1345-1351

2021

Volltextzugriff (PDF)

Performance of standardized patient reported outcomes developed for spondyloarthritis in primary and concomitant forms of fibromyalgia

Arthritis research & therapy, 2024-07, Vol.26 (1), p.141-7, Article 141

2024

Volltextzugriff (PDF)

Head-to-head-Studien zur Röntgenprogression bei axialer Spondyloarthritis

Zeitschrift für Rheumatologie, 2024-05

2024

Volltextzugriff (PDF)

A Bayesian model to analyse the association of comorbidities with biosimilar treatment retention in a non-medical switch scenario in patients with inflammatory rheumatic musculoskeletal diseases

Arthritis research & therapy, 2024-09, Vol.26 (1), p.155-9, Article 155

2024

Volltextzugriff (PDF)

Prevalence and location of inflammatory and structural lesions in patients with rheumatoid arthritis and radiographic axial spondyloarthritis with chronic neck pain evaluated by magnetic resonance imaging

Arthritis research & therapy, 2024-07, Vol.26 (1), p.138-10, Article 138

2024

Volltextzugriff (PDF)

Assessments of Functioning in Patients With Axial Spondyloarthritis

대한류마티스학회지, 2020, 27(1), , pp.22-29

2020

Volltextzugriff (PDF)

Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence

Therapeutic Advances in Musculoskeletal Disease, 2021, Vol.13, p.1759720-1759720X211041854

2021

Volltextzugriff (PDF)

Classification and diagnosis of axial spondyloarthritis--what is the clinically relevant difference?

Journal of rheumatology, 2015-01, Vol.42 (1), p.31-38

2015

Volltextzugriff (PDF)

Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases

Therapeutic advances in musculoskeletal disease, 2022, Vol.14, p.1759720-1759720X221119593

2022

Volltextzugriff (PDF)

SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD

Therapeutic advances in musculoskeletal disease, 2022, Vol.14, p.1759720X221093760

2022

Volltextzugriff (PDF)

Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care

Therapeutic advances in musculoskeletal disease, 2023-01, Vol.15, p.1759720X231197087-1759720X231197087

2023

Volltextzugriff (PDF)

Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials

Rheumatology international, 2022-02, Vol.42 (2), p.205-213

2022

Volltextzugriff (PDF)

Correspondence on “Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial” by Molto et al

Annals of the rheumatic diseases, 2023-12, Vol.82 (12), p.e229-e229

2023

Volltextzugriff (PDF)

Emerging drugs for the treatment of axial and peripheral spondyloarthritis

Expert opinion on emerging drugs, 2015-03, Vol.20 (1), p.1-14

2015

Volltextzugriff (PDF)

Work participation in patients with axial spondyloarthritis: high prevalence of negative workplace experiences and long-term work impairment

Rheumatic & musculoskeletal diseases open, 2023-03, Vol.9 (1), p.e002663

2023

Volltextzugriff (PDF)

Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis: results from phase IV ASTRUM study

Therapeutic advances in musculoskeletal disease, 2024-01, Vol.16, p.1759720X241255486

2024

Volltextzugriff (PDF)

Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study

Rheumatic & musculoskeletal diseases open, 2023-06, Vol.9 (2), p.e002875

2023

Volltextzugriff (PDF)

Erste Klassifikationskriterien für durch Kalziumpyrophosphatablagerungen verursachte Erkrankungen – Übersetzung, Erläuterung und Bewertung

Zeitschrift für Rheumatologie, 2024, Vol.83 (4), p.306-315

2024

Volltextzugriff (PDF)

Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis

Rheumatology and therapy., 2023-12, Vol.10 (6), p.1417-1457

2023

Volltextzugriff (PDF)

Assessments und Outcome-Parameter bei axialer Spondyloarthritis in klinischen Studien und in der täglichen Praxis

Zeitschrift für Rheumatologie, 2023-06, Vol.82 (5), p.380-388

2023

Volltextzugriff (PDF)

Impact of daily physical therapy over 2 weeks on spinal mobility including objective electronic measurements and function in patients with axial spondyloarthritis

Therapeutic advances in musculoskeletal disease, 2024-01, Vol.16, p.1759720X231224212-1759720X231224212

2024

Volltextzugriff (PDF)

arthritis + rheuma – Zeitschrift für Orthopädie und Rheumatologie

Arthritis + Rheuma, 2021-04, Vol.41 (2), p.76-77

2021

Volltextzugriff (PDF)

Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort

Rheumatic & musculoskeletal diseases open, 2023-12, Vol.9 (4), p.e003587

2023

Volltextzugriff (PDF)

Head-to-head studies on radiographic progression in axial spondyloarthritis

Zeitschrift für Rheumatologie, 2024-05

2024

Volltextzugriff (PDF)

1 – 25 von 213

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(195)
Mit Volltextzugriff
(143)

Publikationsform

Artikel
(210)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Treat-to-target in axial spondyloarthritis - what about physical function and activity?

Non-medical switching from reference to biosimilar etanercept - no evidence for nocebo effect: a retrospective analysis of real-life data

Performance of standardized patient reported outcomes developed for spondyloarthritis in primary and concomitant forms of fibromyalgia

Head-to-head-Studien zur Röntgenprogression bei axialer Spondyloarthritis

A Bayesian model to analyse the association of comorbidities with biosimilar treatment retention in a non-medical switch scenario in patients with inflammatory rheumatic musculoskeletal diseases

Prevalence and location of inflammatory and structural lesions in patients with rheumatoid arthritis and radiographic axial spondyloarthritis with chronic neck pain evaluated by magnetic resonance imaging

Assessments of Functioning in Patients With Axial Spondyloarthritis

Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence

Classification and diagnosis of axial spondyloarthritis--what is the clinically relevant difference?

Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases

SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD

Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care

Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials

Correspondence on “Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial” by Molto et al

Emerging drugs for the treatment of axial and peripheral spondyloarthritis

Work participation in patients with axial spondyloarthritis: high prevalence of negative workplace experiences and long-term work impairment

Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis: results from phase IV ASTRUM study

Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study

Erste Klassifikationskriterien für durch Kalziumpyrophosphatablagerungen verursachte Erkrankungen – Übersetzung, Erläuterung und Bewertung

Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis

Assessments und Outcome-Parameter bei axialer Spondyloarthritis in klinischen Studien und in der täglichen Praxis

Impact of daily physical therapy over 2 weeks on spinal mobility including objective electronic measurements and function in patients with axial spondyloarthritis

arthritis + rheuma – Zeitschrift für Orthopädie und Rheumatologie

Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort

Head-to-head studies on radiographic progression in axial spondyloarthritis

Suchergebnisse filtern